|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 5931 |
FusionGeneSummary for CCDC91_FAR2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CCDC91_FAR2 | Fusion gene ID: 5931 | Hgene | Tgene | Gene symbol | CCDC91 | FAR2 | Gene ID | 55297 | 55711 |
| Gene name | coiled-coil domain containing 91 | fatty acyl-CoA reductase 2 | |
| Synonyms | HSD8|p56 | HEL-S-81|MLSTD1|SDR10E2 | |
| Cytomap | 12p11.22 | 12p11.22 | |
| Type of gene | protein-coding | protein-coding | |
| Description | coiled-coil domain-containing protein 91GGA-binding partnerp56 accessory protein | fatty acyl-CoA reductase 2epididymis secretory protein Li 81male sterility domain-containing protein 1short chain dehydrogenase/reductase family 10E, member 2 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q7Z6B0 | Q96K12 | |
| Ensembl transtripts involved in fusion gene | ENST00000539107, ENST00000545336, ENST00000381256, ENST00000381259, ENST00000540401, ENST00000306172, | ENST00000536681, ENST00000549080, ENST00000182377, ENST00000547116, | |
| Fusion gene scores | * DoF score | 11 X 8 X 7=616 | 3 X 2 X 3=18 |
| # samples | 11 | 3 | |
| ** MAII score | log2(11/616*10)=-2.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: CCDC91 [Title/Abstract] AND FAR2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | FAR2 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process | 15220348 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | LGG | TCGA-HT-7873-01B | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000539107 | ENST00000536681 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-intron | ENST00000539107 | ENST00000549080 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-5UTR | ENST00000539107 | ENST00000182377 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-intron | ENST00000539107 | ENST00000547116 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-5UTR | ENST00000545336 | ENST00000536681 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-intron | ENST00000545336 | ENST00000549080 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-5UTR | ENST00000545336 | ENST00000182377 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-intron | ENST00000545336 | ENST00000547116 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-5UTR | ENST00000381256 | ENST00000536681 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-intron | ENST00000381256 | ENST00000549080 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-5UTR | ENST00000381256 | ENST00000182377 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-intron | ENST00000381256 | ENST00000547116 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-5UTR | ENST00000381259 | ENST00000536681 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-intron | ENST00000381259 | ENST00000549080 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-5UTR | ENST00000381259 | ENST00000182377 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| 5CDS-intron | ENST00000381259 | ENST00000547116 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| intron-5UTR | ENST00000540401 | ENST00000536681 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| intron-intron | ENST00000540401 | ENST00000549080 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| intron-5UTR | ENST00000540401 | ENST00000182377 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| intron-intron | ENST00000540401 | ENST00000547116 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| intron-5UTR | ENST00000306172 | ENST00000536681 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| intron-intron | ENST00000306172 | ENST00000549080 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| intron-5UTR | ENST00000306172 | ENST00000182377 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
| intron-intron | ENST00000306172 | ENST00000547116 | CCDC91 | chr12 | 28412375 | + | FAR2 | chr12 | 29423345 | + |
Top |
FusionProtFeatures for CCDC91_FAR2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CCDC91 | FAR2 |
| Involved in the regulation of membrane traffic throughthe trans-Golgi network (TGN). Functions in close cooperation withthe GGAs in the sorting of hydrolases to lysosomes.{ECO:0000269|PubMed:17596511}. | Catalyzes the reduction of saturated but not unsaturatedC16 or C18 fatty acyl-CoA to fatty alcohols. A lower activity canbe observed with shorter fatty acyl-CoA substrates(PubMed:15220348). It may play a role in the production of etherlipids/plasmalogens and wax monoesters which synthesis requiresfatty alcohols as substrates (By similarity).{ECO:0000250|UniProtKB:Q8WVX9, ECO:0000269|PubMed:15220348}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CCDC91_FAR2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CCDC91_FAR2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CCDC91 | TESC, EWSR1, GGA1, GGA2, CCDC91, ECT2, MVK, ANGPTL3, STARD7, C10orf88, CCDC102A, PES1 | FAR2 | PEX19, SLC39A4, VSIG4, ERGIC3, IQCF1, ATP2B2, B4GAT1, SCN3B, PCDHGB1, SLC39A12, CHRNA3, VNN2, GRPR |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CCDC91_FAR2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CCDC91_FAR2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CCDC91 | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|